Authors
Loading...
Randomized trial demonstrates targeting DNA repair improves outcomes in high-grade B-cell lymphoma, suggesting new treatment strategies.
Fusani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: